This discussion should consider the individual's overall health, risk factors, and therapeutic options to make an informed decision about whether to continue or discontinue GLP-1 drugs
47 : 23952400 Paradies G, Ruggiero FM, Gadaleta MN, Quagliariello E
The study also comes after years of political pressure on Novo Nordisk and other drugmakers to slash high costs of diabetes care, especially insulin
Smartphone monitoring halves avoidable cirrhosis readmissions in randomized trial by Doug Brunk Digital tool paired with caregiver engagement lowered 30-day rehospitalizations among patients with cirrhosis in a multicenter trial
Potentially, yes, but this is a decision to make with your prescribing clinician rather than something to do unilaterally
Wegovy is part of a treatment plan that includes reduced-calorie diet and increased physical activity